Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jiang VC"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hao D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lian J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cai Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McIntosh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Santos D; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Badillo M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Leeming A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hartig K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bigcal J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhou J; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriquez A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thirumurthi S; Department of Gastroenterology, Hepathology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wagner-Bartak N; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hill H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nomie K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Flowers C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. lwang22@mdanderson.org., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 07; Vol. 15 (1), pp. 8668. Date of Electronic Publication: 2024 Oct 07.
Autor:
Li Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lee HH; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Che Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., McIntosh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jordan A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Vargas J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Zhang T; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Yan F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Simmons ME; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Nie L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Yao Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. YLiu22@mdanderson.org.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Nov 02; Vol. 14 (11), pp. 714. Date of Electronic Publication: 2023 Nov 02.
Autor:
Che Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Li Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., McIntosh JM; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Jordan A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Yan F; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX., Wang W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Nie L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HH; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Jin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Yao Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Zhao Z; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3361-3365.
Autor:
Li L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Nie L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Jordan A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Cai Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Li Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Che Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Vargas J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Leeming A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Wang W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Yao Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center. cjiang@mdanderson.org.
Publikováno v:
Haematologica [Haematologica] 2023 Jun 01; Vol. 108 (6), pp. 1616-1627. Date of Electronic Publication: 2023 Jun 01.
Autor:
Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Yan F; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Li Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Che Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., McIntosh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Jordan A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Hou I; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Nie L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Jin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HH; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Yao Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX. miwang@mdanderson.org.
Publikováno v:
Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1412-1416. Date of Electronic Publication: 2023 May 01.
Autor:
Li X; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Yang F; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., He N; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Zhang M; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Lv Y; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Yu Y; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Dong Q; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Hou X; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Hao Y; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., An Z; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Zhang H; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Yang Z; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Zhai H; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Guo D; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Cao Z; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Jiang VC; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA., Chen Y; Cothera Bioscience, Inc., 155 Bovet Road, Suite 660, San Mateo, CA 94402, USA. Electronic address: yychen@zkbymed.com.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Feb 01; Vol. 181, pp. 106343. Date of Electronic Publication: 2022 Nov 24.
Autor:
Jiang VC; Department of Lymphoma and Myeloma and., Liu Y; Department of Lymphoma and Myeloma and., Lian J; Department of Lymphoma and Myeloma and., Huang S; Department of Lymphoma and Myeloma and., Jordan A; Department of Lymphoma and Myeloma and., Cai Q; Department of Lymphoma and Myeloma and., Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yan F; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA., McIntosh J; Department of Lymphoma and Myeloma and., Li Y; Department of Lymphoma and Myeloma and., Che Y; Department of Lymphoma and Myeloma and., Chen Z; Department of Lymphoma and Myeloma and., Vargas J; Department of Lymphoma and Myeloma and., Badillo M; Department of Lymphoma and Myeloma and., Bigcal JN; Department of Lymphoma and Myeloma and., Lee HH; Department of Lymphoma and Myeloma and., Wang W; Department of Lymphoma and Myeloma and., Yao Y; Department of Lymphoma and Myeloma and., Nie L; Department of Lymphoma and Myeloma and., Flowers CR; Department of Lymphoma and Myeloma and., Wang M; Department of Lymphoma and Myeloma and.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Feb 01; Vol. 133 (3). Date of Electronic Publication: 2023 Feb 01.
Autor:
Jiang VC; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hao D; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jain P; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Li Y; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Cai Q; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Yao Y; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Nie L; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Liu Y; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Jin J; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang W; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lee HH; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Che Y; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Dai E; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Han G; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang R; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Rai K; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Futreal A; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Flowers C; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang L; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. lwang22@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, 77030, USA. lwang22@mdanderson.org., Wang M; Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. miwang@mdanderson.org.; Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. miwang@mdanderson.org.
Publikováno v:
Molecular cancer [Mol Cancer] 2022 Sep 26; Vol. 21 (1), pp. 185. Date of Electronic Publication: 2022 Sep 26.
Autor:
Ye H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huang S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of cellular and molecular medicine [J Cell Mol Med] 2022 May; Vol. 26 (10), pp. 3068-3073. Date of Electronic Publication: 2022 Mar 30.